Cargando…

Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions

The pancreas has physiologically important endocrine and exocrine functions; secreting enzymes into the small intestine to aid digestion and releasing multiple peptide hormones via the islets of Langerhans to regulate glucose metabolism, respectively. Insulin and glucagon, in combination with ghreli...

Descripción completa

Detalles Bibliográficos
Autores principales: English, Andrew, Irwin, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216561/
https://www.ncbi.nlm.nih.gov/pubmed/32425629
http://dx.doi.org/10.1177/1179551419888871
_version_ 1783532435264241664
author English, Andrew
Irwin, Nigel
author_facet English, Andrew
Irwin, Nigel
author_sort English, Andrew
collection PubMed
description The pancreas has physiologically important endocrine and exocrine functions; secreting enzymes into the small intestine to aid digestion and releasing multiple peptide hormones via the islets of Langerhans to regulate glucose metabolism, respectively. Insulin and glucagon, in combination with ghrelin, pancreatic polypeptide and somatostatin, are the main classical islet peptides critical for the maintenance of blood glucose. However, pancreatic islets also synthesis numerous ‘nonclassical’ peptides that have recently been demonstrated to exert fundamental effects on overall islet function and metabolism. As such, insights into the physiological relevance of these nonclassical peptides have shown impact on glucose metabolism, insulin action, cell survival, weight loss, and energy expenditure. This review will focus on the role of individual nonclassical islet peptides to stimulate pancreatic islet secretions as well as regulate metabolism. In addition, the more recognised actions of these peptides on satiety and energy regulation will also be considered. Furthermore, recent advances in the field of peptide therapeutics and obesity-diabetes have focused on the benefits of simultaneously targeting several hormone receptor signalling cascades. The potential for nonclassical islet hormones within such combinational approaches will also be discussed.
format Online
Article
Text
id pubmed-7216561
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72165612020-05-18 Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions English, Andrew Irwin, Nigel Clin Med Insights Endocrinol Diabetes Peptide-based Therapies in Diabetes The pancreas has physiologically important endocrine and exocrine functions; secreting enzymes into the small intestine to aid digestion and releasing multiple peptide hormones via the islets of Langerhans to regulate glucose metabolism, respectively. Insulin and glucagon, in combination with ghrelin, pancreatic polypeptide and somatostatin, are the main classical islet peptides critical for the maintenance of blood glucose. However, pancreatic islets also synthesis numerous ‘nonclassical’ peptides that have recently been demonstrated to exert fundamental effects on overall islet function and metabolism. As such, insights into the physiological relevance of these nonclassical peptides have shown impact on glucose metabolism, insulin action, cell survival, weight loss, and energy expenditure. This review will focus on the role of individual nonclassical islet peptides to stimulate pancreatic islet secretions as well as regulate metabolism. In addition, the more recognised actions of these peptides on satiety and energy regulation will also be considered. Furthermore, recent advances in the field of peptide therapeutics and obesity-diabetes have focused on the benefits of simultaneously targeting several hormone receptor signalling cascades. The potential for nonclassical islet hormones within such combinational approaches will also be discussed. SAGE Publications 2019-12-12 /pmc/articles/PMC7216561/ /pubmed/32425629 http://dx.doi.org/10.1177/1179551419888871 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Peptide-based Therapies in Diabetes
English, Andrew
Irwin, Nigel
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title_full Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title_fullStr Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title_full_unstemmed Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title_short Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
title_sort nonclassical islet peptides: pancreatic and extrapancreatic actions
topic Peptide-based Therapies in Diabetes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216561/
https://www.ncbi.nlm.nih.gov/pubmed/32425629
http://dx.doi.org/10.1177/1179551419888871
work_keys_str_mv AT englishandrew nonclassicalisletpeptidespancreaticandextrapancreaticactions
AT irwinnigel nonclassicalisletpeptidespancreaticandextrapancreaticactions